These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3859973)

  • 1. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kliogest--the possibility of hormonal substitution in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1993; 32(3):64-6. PubMed ID: 8037328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
    Staland B
    Maturitas; 1981 Aug; 3(2):145-56. PubMed ID: 7026979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
    Fink BJ
    Maturitas; 1984 Apr; 5(4):277-80. PubMed ID: 6738374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
    Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined estrogen and progestogen for the menopause.
    Mugglestone CJ; Swinhoe JR; Craft IL
    Acta Obstet Gynecol Scand; 1980; 59(4):327-9. PubMed ID: 7004052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Gräser T; Koytchev R; Müller A; Oettel M
    Climacteric; 2000 Jun; 3(2):109-18. PubMed ID: 11910651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints.
    Mattsson LA; Cullberg G; Samsioe G
    Maturitas; 1982 Aug; 4(2):95-102. PubMed ID: 7121296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal therapy and endometrial pathology.
    Craft I; Swinhoe J; Mugglestone CJ
    Br Med J; 1978 Aug; 2(6134):429-30. PubMed ID: 687955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
    Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
    Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal hormonal replacement therapy with transdermal progestin every second month.
    Lindgren R; Risberg B; Hammar M; Berg G
    Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints.
    Sporrong T; Hellgren M; Samsioe G; Mattsson LA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1042-8. PubMed ID: 3056498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.